Singapore markets closed

Aurinia Pharmaceuticals Inc. (AUPH)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
4.9100+0.0400 (+0.82%)
At close: 04:00PM EDT
4.9000 -0.01 (-0.20%)
After hours: 04:42PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
175,513
175,513
134,030
45,605
50,118
Cost of revenue
14,148
14,148
5,664
1,091
0
Gross profit
161,365
161,365
128,366
44,514
50,118
Operating expenses
Research development
49,641
49,641
44,988
51,139
50,327
Selling general and administrative
195,036
195,036
196,371
173,536
97,272
Total operating expenses
253,056
253,056
239,836
225,249
154,408
Operating income or loss
-91,691
-91,691
-111,470
-180,735
-104,290
Interest expense
2,775
2,775
0
0
-
Total other income/expenses net
-
-
-
-
-6,809
Income before tax
-77,469
-77,469
-106,352
-180,206
-102,774
Income tax expense
551
551
1,828
760
-94
Income from continuing operations
-78,020
-78,020
-108,180
-180,966
-102,680
Net income
-78,020
-78,020
-108,180
-180,966
-102,680
Net income available to common shareholders
-78,020
-78,020
-108,180
-180,966
-102,680
Basic EPS
-0.54
-0.54
-0.76
-1.40
-0.87
Diluted EPS
-0.54
-0.54
-0.76
-1.40
-0.87
Basic average shares
142,856
143,236
141,915
129,369
118,473
Diluted average shares
142,856
143,236
141,915
129,369
118,473